Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Obesity Surgery|October 7, 2022
Factors Associated with Increased Severity of Erosive Esophagitis 1 Year After Laparoscopic Sleeve GastrectomyYing-Nan Tsai, Chi-Ming Tai, Hung-Pin Tu, et al.
Gastrointestinal Endoscopy|April 7, 2024
Administration of oral prednisolone to prevent esophageal stricture after balloon-type radiofrequency ablation for ultralong-segment esophageal neoplasiaWen-Lun Wang, Ying-Nan Tsai, Ming-Hung Hsu, et al.
Journal of Gastroenterology and Hepatology|July 10, 2026
Comparative Effectiveness and Safety of Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab as First-Line Systemic Therapy for Hepatocellular Carcinoma: A Real-World StudyShu Hsien Lin, Jia-Ling Wu, Ying-Nan Tsai, et al.
The Kaohsiung Journal of Medical Sciences|January 10, 2018
Endoluminal stenting for the management of leak following sleeve gastrectomy and loop duodenojejunal bypass with sleeve gastrectomyYing-Nan Tsai, Hsiu-Po Wang, Chih-Kun Huang, et al.
Infection|March 28, 2026
Clinical utility of non-induced sputum galactomannan testing for suspected invasive pulmonary aspergillosis: a real-world retrospective cohort studyChia-Ta Tsai, Shin-Yi Liang, Chung-Hsu Lai, et al.
Gastrointestinal Endoscopy|November 9, 2024
Endoscopic background mucosal resurfacing to prevent metachronous recurrence of superficial esophageal squamous cell cancer after curative endoscopic submucosal dissection: randomized pilot study with 5-year follow-up (with video)Wen-Lun Wang, Ying-Nan Tsai, Ming-Hung Hsu, et al.
Scientific Reports|October 30, 2022
Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomasChi-Jen Chen, Ching-Tai Lee, Ying-Nan Tsai, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2025
Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog WithdrawalYing-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, et al.
Alimentary Pharmacology & Therapeutics|June 7, 2025
Factors Associated With Underutilization of Antiviral Therapy in Preventing Hepatitis B Virus-Related Hepatocellular CarcinomaJia-Ling Wu, Ying-Nan Tsai, Cheng-Hao Tseng, et al.
Alimentary Pharmacology & Therapeutics|April 7, 2026
Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg LossYing-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, et al.
Pageof 2